Compounds > 1-(3-chlorophenyl)piperazine
Page last updated: 2024-10-21

1-(3-chlorophenyl)piperazine and Heart Valve Diseases

1-(3-chlorophenyl)piperazine has been researched along with Heart Valve Diseases in 1 studies

1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.

Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rothman, RB1
Baumann, MH1
Savage, JE1
Rauser, L1
McBride, A1
Hufeisen, SJ1
Roth, BL1

Other Studies

1 other study available for 1-(3-chlorophenyl)piperazine and Heart Valve Diseases

ArticleYear
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
    Circulation, 2000, Dec-05, Volume: 102, Issue:23

    Topics: Dose-Response Relationship, Drug; Ergotamine; Fenfluramine; Heart Valve Diseases; Humans; Methylergo

2000